PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung disease |
| Symptom | C0020542|pulmonary hypertension |
| Sentences | 49 |
| PubMedID- 26293503 | Severe pulmonary hypertension in lung disease: phenotypes and response to treatment. |
| PubMedID- 26115628 | Management of pulmonary hypertension in patients with chronic lung disease. |
| PubMedID- 20092992 | pulmonary hypertension in lung diseases: survey of beliefs and practice patterns. |
| PubMedID- 21693294 | Effect of pulmonary hypertension in patients with end-stage lung disease on posttransplantation outcomes. |
| PubMedID- 25006405 | Tada-phild (tadalafil for pulmonary hypertension associated with chronic obstructive lung disease) is the first sufficiently powered randomized clinical trial testing the effect of pde-5i on key clinical and drug safety outcome measures in patients with at least moderate ph due to copd. |
| PubMedID- 26453478 | Purpose: recent imaging studies demonstrated the usefulness of quantitative computed tomographic (ct) analysis assessing pulmonary hypertension (ph) in patients with chronic obstructive lung disease (copd-ph). |
| PubMedID- 22936711 | We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung disease (ph-ild). |
| PubMedID- 21613438 | Purpose: to study the reliability of pulmonary vascular measurements based on computed tomography (ct) in the prediction of pulmonary hypertension (ph) in patients with advanced interstitial lung disease (ild) compared with those without ild. |
| PubMedID- 21536179 | Therapy specific for pulmonary arterial hypertension, poorly evaluated in pulmonary hypertension associated with infiltrative lung diseases, is occasionally proposed to patients with disproportionate pulmonary hypertension (mean pap > 35 mmhg), with often limited efficacy, and requiring careful follow-up (risk of increased hypoxemia) and invasive evaluation. |
| PubMedID- 24697923 | Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with pde-5 inhibitors. |
| PubMedID- 23097665 | It is recommended, in particular for patients with chronic lung disease as a cause of pulmonary hypertension, that an examination of pulmonary function and an arterial blood gas analysis be conducted prior to the surgical intervention . |
| PubMedID- 22221973 | pulmonary hypertension due to chronic lung disease: updated recommendations of the cologne consensus conference 2011. |
| PubMedID- 25046428 | pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis. |
| PubMedID- 25378843 | the prevalence of isolated pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease in systemic sclerosis were similar and ranged between 18 and 22% in various studies. |
| PubMedID- 23009908 | pulmonary hypertension in the setting of parenchymal lung disease and conditions associated with chronic hypoxemia is commonly encountered in clinical practice and may adversely affect patients' function and mortality. |
| PubMedID- 20819757 | Chronic hypoxia is the major mechanism implicated for the development of pulmonary hypertension in patients with lung diseases. |
| PubMedID- 23354416 | pulmonary hypertension is often associated with inflammatory lung diseases, for example chronic obstructive pulmonary disease, or autoimmune diseases. |
| PubMedID- 25954555 | Despite aggressive intervention, he continued to be ventilator dependent with worsening pulmonary hypertension due to chronic lung disease. |
| PubMedID- 23797369 | We tested whether sscpah or systemic sclerosis-related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than ipah and leads to worse rv contractile function. |
| PubMedID- 23841910 | Severe obstructive lung disease with pulmonary hypertension may be a contraindication for lung flooding. |
| PubMedID- 23920210 | Background: pulmonary hypertension is frequently associated with parenchymal lung disease. |
| PubMedID- 26361668 | pulmonary hypertension (ph) associated with lung diseases not only is an index of poor outcome but also is an indication for bilateral procedure. |
| PubMedID- 20522579 | pulmonary hypertension (ph) associated with parenchymal lung diseases is one of the most common forms of ph. |
| PubMedID- 25183617 | We report the case of a 75-years-old man who diagnosed with severe pulmonary hypertension, associated with interstitial lung disease characterized by a rapid and fatal outcome. |
| PubMedID- 24671311 | Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis. |
| PubMedID- 26473476 | However, our study could not adjust for pulmonary hypertension, a complication of interstitial lung disease, including idiopathic lung fibrosis. |
| PubMedID- 21719760 | Rationale: senescence of pulmonary artery smooth muscle cells (pa-smcs) caused by telomere shortening or oxidative stress may contribute to pulmonary hypertension associated with chronic lung diseases. |
| PubMedID- 20920139 | The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 21182801 | Compared with pah, the pathological changes of pulmonary hypertension due to lung diseases and/or hypoxia are characterized by medial hypertrophy and intimal obstructive proliferation of the distal pulmonary arteries . |
| PubMedID- 26029619 | Some patients with group 3 pulmonary hypertension (ph) (ph due to lung disease and/or hypoxia) exhibit disproportionately advanced or "out-of-proportion" ph. |
| PubMedID- 26283756 | Objectives: this study was conducted to evaluate the value of sonographic b-lines (previously called "comet tail artifacts") in assessment of pulmonary hypertension in patients with interstitial lung diseases. |
| PubMedID- 24267299 | pulmonary hypertension due to lung disease and/or hypoxia. |
| PubMedID- 26029570 | We also present a review of the literature on treatment of pulmonary hypertension in patients with chronic lung disease. |
| PubMedID- 26166793 | pulmonary hypertension in the course of diffuse parenchymal lung diseases - state of art and future considerations. |
| PubMedID- 22884387 | Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. |
| PubMedID- 21474572 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 21266048 | Background: chronic alveolar hypoxia, due to residence at high altitude or chronic obstructive lung diseases, leads to pulmonary hypertension, which may be further complicated by right heart failure, increasing morbidity and mortality. |
| PubMedID- 25076998 | Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary hypertension due to lung diseases and/or hypoxia. |
| PubMedID- 23884296 | Pulmonary arterial hypertension, pulmonary hypertension due to lung disease, or chronic thromboembolic pulmonary hypertension; phpvd), from those with left heart disease associated pulmonary hypertension (pulmonary venous hypertension; pvh) is crucial as workup and treatment options differ dramatically. |
| PubMedID- 20862620 | pulmonary hypertension due to chronic lung disease. |
| PubMedID- 21181642 | pulmonary hypertension due to chronic lung disease. |
| PubMedID- 22415303 | The a2b adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 25813769 | Background: pulmonary hypertension associated with lung disease (phld) has been shown to be a predictor of disease severity and survival in patients awaiting lung transplantation. |
| PubMedID- 25613108 | Role of bnp and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model. |
| PubMedID- 22034605 | patients with pulmonary hypertension associated with underlying lung diseases such as chronic obstructive pulmonary disease (copd), pulmonary fibrosis, and sarcoidosis, also are at increased risk of mortality, and those with combined emphysema, interstitial lung disease and pulmonary hypertension have a particularly high mortality risk, with only a 60% one-year survival. |
| PubMedID- 25025352 | pulmonary hypertension due to fibrotic lung disease: hidden value in a neutral trial. |
| PubMedID- 21538327 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. |
| PubMedID- 22958673 | Patients with lung diseases associated with pre-existing pulmonary hypertension (mean pap > 25 mm hg at rest) are advised against high altitude travel. |
| PubMedID- 21941650 | Signs of chronic heart disease, pulmonary fibrosis, or emphysema suggest that patients may have pulmonary venous hypertension or pulmonary hypertension associated with chronic lung disease rather than pah. |
Page: 1